CIBC World Market’s Repare Therapeutics RPTX Stock Holding History

CIBC World Market’s Portfolio RPTX Stock Details RPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,500	Closed	-$27.3K	–	1586
2025 Q4	$27.3K	Hold	10,500	–	–	﹤0.01%	1431
2025 Q3	$18.5K	Hold	10,500	–	–	﹤0.01%	1402
2025 Q2	$14.6K	Sell	10,500 -2	-0%	-$3	﹤0.01%	1349
2025 Q1	$10.4K	Buy	10,502 +2	+0%	+$2	﹤0.01%	1349
2024 Q4	$14K	Hold	10,500	–	–	﹤0.01%	1349
2024 Q3	$36K	Hold	10,500	–	–	﹤0.01%	1283
2024 Q2	$35K	Hold	10,500	–	–	﹤0.01%	1247
2024 Q1	$49K	Hold	10,500	–	–	﹤0.01%	1266
2023 Q4	$77K	Buy	+10,500	New	+$58.7K	﹤0.01%	1212

CIBC World Market's RPTX Position: Q1 2026 in Review

CIBC World Market sold out of Repare Therapeutics (RPTX) in Q1 2026, closing a stake of 10,500 shares — an estimated $27.3K sold.

CIBC World Market first reported a position in RPTX in Q4 2023 and held it in 9 quarters. The position peaked at $77K in Q4 2023. 0 funds tracked by Wall St. Rank hold RPTX as of Q1 2026.

CIBC World Market reported no remaining Repare Therapeutics position as of Q1 2026 after selling out during the quarter.
CIBC World Market sold 10,500 Repare Therapeutics shares in Q1 2026, an estimated $27.3K.
CIBC World Market first reported a position in Repare Therapeutics in Q4 2023 and held it in 9 quarters.
CIBC World Market's Repare Therapeutics position peaked at $77K in Q4 2023.
0 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2026.

Based on CIBC World Market's 13F filing for Q1 2026, filed 14 May 2026.